QN9

(4S)-6-chloro-4-{2-[4-(3-hydroxypropyl)piperazin-1-yl]-2-oxoethyl}-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide

Created:	2023-08-18
Last modified:	2023-11-08

Find Related PDB Entry
1 entries where QN9 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	1
Bond Count	72
Aromatic Bond Count	17

2D diagram of QN9

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(4S)-6-chloro-4-{2-[4-(3-hydroxypropyl)piperazin-1-yl]-2-oxoethyl}-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide
Systematic Name (OpenEye OEToolkits)	(4~{S})-6-chloranyl-~{N}-isoquinolin-4-yl-4-[2-oxidanylidene-2-[4-(3-oxidanylpropyl)piperazin-1-yl]ethyl]-2,3-dihydrochromene-4-carboxamide
Formula	C₂₈ H₃₁ Cl N₄ O₄
Molecular Weight	523.023
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OCCCN1CCN(CC1)C(=O)CC1(CCOc2ccc(Cl)cc21)C(=O)Nc1cncc2ccccc21
SMILES	CACTVS	3.385	OCCCN1CCN(CC1)C(=O)C[C]2(CCOc3ccc(Cl)cc23)C(=O)Nc4cncc5ccccc45
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)cncc2NC(=O)C3(CCOc4c3cc(cc4)Cl)CC(=O)N5CCN(CC5)CCCO
Canonical SMILES	CACTVS	3.385	OCCCN1CCN(CC1)C(=O)C[C@]2(CCOc3ccc(Cl)cc23)C(=O)Nc4cncc5ccccc45
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)cncc2NC(=O)[C@@]3(CCOc4c3cc(cc4)Cl)CC(=O)N5CCN(CC5)CCCO
InChI	InChI	1.06	InChI=1S/C28H31ClN4O4/c29-21-6-7-25-23(16-21)28(8-15-37-25,17-26(35)33-12-10-32(11-13-33)9-3-14-34)27(36)31-24-19-30-18-20-4-1-2-5-22(20)24/h1-2,4-7,16,18-19,34H,3,8-15,17H2,(H,31,36)/t28-/m0/s1
InChIKey	InChI	1.06	WROWCVDJFRRWBJ-NDEPHWFRSA-N

Related Resource References

Resource Name	Reference
PubChem	156906579

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.